The AI That Caught What Every Doctor Missed — Genome-Powered Medicine Is Here with Dr. Don Brown

In this episode of The Empowering Neurologist, Dr. David Perlmutter sits down with Dr. Don Brown — a rare triple-threat as physician, computer scientist, and entrepreneur — to explore how artificial intelligence is beginning to fulfill medicine's long-unfulfilled promise of true prevention. Brown opens by diagnosing why prevention has historically stalled: the human body generates far more biological signal than any clinician can synthesize in a standard encounter, and the healthcare system is structurally rewarded for treating disease rather than preventing it.

Brown describes how modern AI systems can now integrate disparate data streams — genomic sequences, microbiome composition, metabolomics, lifestyle factors, and environmental exposures — into a unified, individual-level health picture. Rather than applying population-level guidelines to every patient, this approach enables genuinely personalized risk stratification. For longevity-focused clinicians, this means interventions can be targeted to the specific vulnerabilities encoded in a person's biology before those vulnerabilities manifest as disease.

The episode's most compelling moment centers on a real-world case study: a patient suffering from symptoms consistent with restless leg syndrome had seen multiple physicians without resolution. An AI system, reviewing the patient's full data profile, flagged chronic arsenic toxicity as the underlying cause — a connection no individual clinician had made. Brown uses this case to illustrate both the diagnostic power of AI and the danger of pattern-matching within narrow specialty silos.

Perlmutter and Brown also discuss the neurodegenerative disease angle specifically, noting that conditions like Alzheimer's and Parkinson's have decades-long prodromal phases during which intervention could theoretically alter trajectory. AI's ability to detect early biomarker shifts — in inflammation, mitochondrial function, or gut-brain axis signaling — opens a window for intervention that conventional annual checkups simply cannot provide.

The conversation closes on the near-term horizon: Brown believes genome-powered AI medicine is not a distant aspiration but an emerging clinical reality. He encourages both clinicians and health-conscious individuals to begin thinking of their genomic and microbiome data as foundational health assets, and to seek out practitioners and platforms equipped to interpret that data through an AI lens.